Journal
ONCOLOGIST
Volume 14, Issue 4, Pages 369-377Publisher
WILEY
DOI: 10.1634/theoncologist.2008-0119
Keywords
Fluorodeoxyglucose; Positron emission tomography; Chemotherapy; Radiotherapy; Response
Categories
Ask authors/readers for more resources
The use of fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of tumor response to chemotherapy and radiation therapy has been studied in a number of malignancies. By imaging tumor metabolism and therapy-related changes, FDG-PET has demonstrated advantages over anatomical imaging in the assessment of treatment response. More recent investigations have indicated that FDG-PET can predict tumor response early during the course of therapy, potentially allowing for early treatment adjustments. The aim of this review is to provide oncologists with a basic knowledge of the practical aspects of PET quantification for treatment. The Oncologist 2009; 14: 369-377
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available